Susceptibility of glycolytic enzyme activity and motility of spermatozoa from rat, mouse, and human to inhibition by proven and putative chlorinated antifertility compounds in vitro
W. Bone et al., Susceptibility of glycolytic enzyme activity and motility of spermatozoa from rat, mouse, and human to inhibition by proven and putative chlorinated antifertility compounds in vitro, J ANDROLOGY, 22(3), 2001, pp. 464-470
Nonhormonal contraceptives that act by blocking energy metabolism within sp
erm have the advantage over spermatogenic inhibitors by their fast onset of
infertility and their almost immediate restoration of fertility after with
drawal of the contraceptive agent. This study was done to test new chlorina
ted compounds for their contraceptive potency on rodent and human sperm in
vitro. Cells were incubated in a medium containing glucose as the sole ener
gy source with 1-chloro-3-hydroxypropanone (CHOP) and 1,6-dichloro-1,6-dide
oxy-D-fructose (DGDF), chlorinated analogues of glycolytic substrates, as w
ell as racemic (R,S)-alpha -chlorohydrin (ACH). After incubation, enzymatic
activity and kinematic parameters were estimated. A dose-dependent inhibit
ion of the glycolytic enzyme, glyceraldehyde 3-phosphate dehydrogenase (GAP
DH), of rat and mouse distal cauda epididymidal and human ejaculated sperm
by AGH, CHOP, and DCDF was demonstrated. Triosephosphate isomerase (TPI) wa
s inhibited by AGH, but not by CHOP and DCDF, irrespective of species. All
compounds inhibited sperm motility and kinematic parameters with increasing
concentration. The results confirm that inhibition of glycolytic enzymes o
f sperm, including those of human, can be effectively brought about by a va
riety of chloro-compounds that can be converted to (s)-3-chlorolactaldehyde
, the stereospecific chloro-derivative of the enzyme's natural substrate, (
R)-glyceraldehyde 3-phosphate, and could be developed into contraceptive ag
ents for men.